Skip to content
Home
Team
Therapies
Overview/Pipeline
IC/BPS
Alenura™
Investor
News
Contact Us
Investor Login

Vaneltix Pipeline Represents Best In-Class Treatments for Urologic Disorders

Alenura

Preclinical

Phase I

Phase II

Phase III

Commercial

Relief of painful symptoms of IC/BPS

Alenura
diagnostic claim

Fast diagnosis of pelvic pain originating from the bladder

VNX002 Biologic

Anabolic therapy for promoting regeneration of damaged urothelium

VNX003 Oral

Improved formulation of current IC/BPS drug Elmiron

VNX004 Topical

Enhanced topical pain relief

Alenura
Phase II

Relief of painful symptoms of IC/BPS

Alenura diagnostic claim
Phase II

Fast diagnosis of pelvic pain originating from the bladder

VNX002 Biologic
Pre-clinical

Anabolic therapy for promoting regeneration of damaged urothelium

VNX003 Oral
Pre-clinical

Improved formulation of current IC/BPS drug Elmiron

VNX004 Topical
Pre-clinical

Enhanced topical pain relief

VNX002

Novel treatment for healing and regeneration of damaged bladder epithelium.

Anabolic biologic therapy for stimulating growth of bladder epithelium treating hemorrhagic cystitis resulting from physical trauma, radiation and chemotherapy for cancer, and severe forms of interstitial cystitis and Hunner’s lesions.

VNX003

Improved oral formulation of pentosan polysulfate (Elmiron).

An improved oral formulation with better absorption and targeting of the bladder will overcome limitations of current marketed products. VNX003 will require lower doses of the active ingredient overcoming GI discomfort and the potential for targeting delivery to the bladder will reduce systemic exposure and associated possible side effects.

VNX004

Vaneltix has shown that alkalinized lidocaine can provide enhanced pain relief over traditional lidocaine formulations.

VNX004 uses the technology and intellectual property that makes Alenura an improved anesthetic formulation for the treatment of bladder pain and incorporates it into novel topical dosage forms for new indications.

IC/BPS Is a Bladder Disorder That Significantly Impacts Normal Daily Activities for Millions of patients

Learn More

Vaneltix Product Alenura Will Provide Relief to Patients’ Painful Symptoms of IC/BPS

Learn More
Vaneltix Pharma, Inc.
305 E High Street, Ste. 7,
Bound Brook, NJ 08805
United States
  • Tel:

    (732) 369-5911
  • Fax:

    (732) 356-1125
  • Email:

    Info@vaneltix.com
Team
Therapies
Investor
News
Contact Us
2021 © Vaneltix. All rights reserved.
Privacy Policy
Privacy Policy
This website is created by Blink.